Comprehensive Guide to Prostate Cancer: History, Prevention, and Treatment

1. Introduction

Prostate cancer is one of the most common types of cancer diagnosed in men worldwide. It occurs in the prostate, a small walnut-shaped gland in males that produces the seminal fluid that nourishes and transports sperm. While some types of prostate cancer grow slowly and may require minimal or even no treatment, other types are aggressive and can spread quickly. This document provides a comprehensive overview of prostate cancer, encompassing its historical context, prevention strategies, specific nutritional guidelines (including emerging research on walnuts and other superfoods), conventional treatments, and anecdotal insights.

2. Historical Context and Background

Understanding the history of prostate cancer provides insight into how far medical science has progressed in its diagnosis and treatment.

  • Early Discovery: The prostate gland was first formally described by the Venetian anatomist Niccolò Massa in 1536. However, prostate cancer itself was not identified until 1853 by surgeon J. Adams, who noted it as a “very rare disease” during a histological examination.
  • Surgical Milestones: The first surgical removal of the prostate to treat cancer (radical perineal prostatectomy) was performed in 1904 by Hugh Hampton Young at Johns Hopkins Hospital.
  • Hormonal Link: In 1941, Charles Huggins and Clarence Hodges published highly influential research demonstrating that prostate cancer cells depend on androgens (male hormones like testosterone) to grow. They discovered that reducing testosterone levels through surgical or medical castration could cause tumours to shrink, a breakthrough that earned Huggins the Nobel Prize in 1966.
  • The PSA Era: The Prostate-Specific Antigen (PSA) test was discovered in the 1970s and approved by regulatory bodies in the 1980s. It revolutionised prostate cancer screening, allowing doctors to detect the disease much earlier than before, drastically altering survival rates and treatment timelines.

3. Understanding the Disease

3.1 Biology and Pathology

Prostate cancer typically begins as a mutation in the glandular cells of the prostate (adenocarcinoma). As the tumour grows, it can remain localised within the prostate capsule or spread (metastasise) to nearby organs, lymph nodes, or bones.

3.2 Risk Factors

  • Age: The risk increases significantly after age 50. Most cases are diagnosed in men over 65.
  • Race/Ethnicity: Men of African and Caribbean descent have the highest incidence rates and are more likely to develop aggressive forms of the disease.
  • Family History and Genetics: Having a first-degree relative (father or brother) with prostate cancer more than doubles a man’s risk. Inherited mutations in genes like BRCA1, BRCA2, and HOXB13 also play a critical role.
  • Geography: It is most common in North America, Northwestern Europe, Australia, and Caribbean islands, potentially pointing to dietary and environmental factors.

3.3 Diagnosis and Staging

Diagnosis typically involves a DRE (Digital Rectal Examination) and a PSA blood test. If abnormalities are detected, an MRI and a subsequent prostate biopsy are performed. The aggressiveness of the cancer is graded using the Gleason Score (ranging from 6 for low-grade to 10 for highly aggressive cancer).

4. Important Nutritional Components, Bioavailability, and Diet

Dietary choices form a cornerstone of prostate cancer prevention and long-term management. However, simply consuming protective foods is not always enough; understanding bioavailability, how efficiently the body absorbs and processes these nutrients, is key to building a truly effective preventive diet.

4.1 Enhanced and Absorbable Nutritional Sources

  • Lycopene (Optimised via Heat and Healthy Fats): While fresh watermelons and pink grapefruits contain raw lycopene, the nutrient is highly bound within plant cell walls. Tomato purée, paste, and cooked tomato sauces offer massively concentrated, highly bioavailable forms of lycopene because the heating process breaks down these cell walls. Furthermore, lycopene is fat-soluble; consuming tomato purée cooked with a dash of extra virgin olive oil increases absorption exponentially (Sun dried tomatoes in extra virgin olive oil (with garlic & herbs)).
  • Isoflavones (The Role of Whole and Fermented Soya): Populations consuming soya products display significantly lower rates of prostate cancer. Isoflavones (such as genistein) weakly bind to oestrogen receptors, mitigating androgenic stimulation.

A Quick Note on Soya Quality: There is sometimes a misconception that unfermented soya is harmful or carcinogenic, but extensive epidemiological research shows that whole, minimally processed soya foods like tofu and edamame are remarkably safe and strongly protective against aggressive prostate cancer. For the highest bioavailability and digestive ease, fermented soya options, such as tempeh, miso, and naturally brewed, high-quality soya sauce (tamari or shoyu), provide easily absorbable isoflavones, though soya sauce should be used in moderation due to its sodium content. Avoid highly processed, chemical-extracted soya protein isolates found in generic meal-replacement bars or fast-food fillers.

  • Cruciferous Vegetables (Activated via Mechanical Chopping): Broccoli, cauliflower, and Brussels sprouts contain glucosinolates, which convert into the anti-cancer compound sulforaphane. The enzyme responsible for this conversion (myrosinase) is activated by chewing or chopping. To maximise bioavailability, chop broccoli or cabbage 30 to 40 minutes before light steaming, or add a pinch of raw mustard seed powder to cooked cruciferous dishes to replace heat-damaged enzymes.
  • Green Tea (Steeping for Potency): To extract the maximum amount of the powerful polyphenol EGCG (epigallocatechin gallate), loose green tea leaves should be steeped in hot (but not boiling) water for 3 to 5 minutes. Adding a splash of citrus juice like lemon (Add roughly 15–20 ml, about half a lemon of fresh juice to your cup) stabilises EGCG in the gut, dramatically enhancing its absorption rate.
  • Omega-3 Fatty Acids (Direct vs. Indirect Sources): Found natively in small, oily, wild-caught fish (sardines, mackerel, and wild salmon) as direct EPA and DHA. For plant-based alternatives, raw walnuts and flaxseeds provide Alpha-Linolenic Acid (ALA), an omega-3 precursor.

4.2 Spotlight on Walnuts: Emerging Preclinical and Clinical Evidence

Preclinical studies heavily suggest that a diet enriched with walnuts can protect prostate health, limit the growth of existing tumours, and slow cancer progression. Researchers have been actively exploring how these dietary benefits translate to human patients. The American Institute for Cancer Research (AICR) officially recognises the anti-cancer potential of walnuts due to their unique complex of beneficial compounds.

  • Tumour Growth and Size: In studies using mice genetically programmed to develop prostate cancer, diets containing walnuts significantly slowed the rate of tumour growth and reduced final tumour size by nearly half compared to control diets.
  • Metabolic Protection and Human Trials: Walnuts have been shown to lower blood levels of insulin-like growth factor-1 (IGF-1) and LDL cholesterol, both of which are strongly linked to tumour progression. Early human studies, such as the cross-over trial detailed by Spaccarotella et al. (PMC2412899), have investigated the effect of a walnut-supplemented diet (75g/day) on prostate health factors in older men. These studies represent crucial steps in proving that dietary changes can be safely implemented without adverse weight gain, paving the way for larger clinical efficacy trials.
  • Cellular Mechanism: Bioactive compounds found abundantly in walnuts, such as omega-3 fatty acids, polyphenols, and ellagitannins, work synergistically to reduce inflammation and affect regulatory mechanisms inside cancer cells, effectively inhibiting tumour expansion and encouraging apoptosis.

4.3 Dietary Elements to Limit or Avoid

  • High-Fat and Ultra-Pasteurised Dairy: Regular consumption of high-fat dairy products (such as whole milk and hard cheeses) is linked with elevated prostate cancer risk in several clinical cohorts, likely due to high calcium concentrations altering vitamin D metabolism.
  • Charred Red and Processed Meats: Grilling, barbecuing, or frying meats at high temperatures forms heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), which damage cellular DNA.
  • Industrial Trans-Fats and Ultra-Processed Foods: Diets dominant in refined sugars, hydrogenated oils, and chemical additives induce systemic inflammation and insulin spikes, feeding the metabolic pathways that cancers exploit to proliferate.

5. Prevention Strategies (Lifestyle and Anecdotal Evidence)

Beyond clinical nutrition, lifestyle factors play an immense role in any prevention programme.

5.1 Evidence-Based Lifestyle Prevention

  • Exercise: Regular vigorous physical activity (3+ hours a week) is associated with a lower risk of developing aggressive prostate cancer.
  • Weight Management: Obesity is strongly linked to aggressive prostate cancer. Fat tissue produces inflammatory proteins and alters hormone levels, creating a microenvironment conducive to cancer growth.
  • Ejaculation Frequency: The Harvard Health Professionals Follow-Up Study observed that men who ejaculated more frequently (21 or more times a month) had a roughly 20% lower risk of developing prostate cancer compared to those who ejaculated 4 to 7 times a month. Ejaculation Frequency and Prostate Cancer. Harvard Medical School.

5.2 Anecdotal and Complementary Approaches

  • Stress Reduction: Practices like yoga, meditation, and deep breathing are highly praised by patients for managing the psychological burden of a cancer diagnosis and theoretically reducing systemic inflammation.
  • Plant-Based Diets: Many patients transition to strict whole-food, plant-based vegan diets after diagnosis, reporting lower PSA progression. Intensive lifestyle change programmes have provided clinical backing for this, showing they could lower PSA and alter genetic expression.

6. Conventional Treatment Options

Treatment is highly individualised based on the cancer’s stage, the patient’s age, and overall health.

6.1 Active Surveillance (Watchful Waiting)

Aggressive treatment may not be necessary straight away for older men or those with low-grade tumours (Gleason 6). Active surveillance involves monitoring the cancer closely with regular PSA tests, DREs, and periodic biopsies.

6.2 Surgery (Radical Prostatectomy)

The surgical removal of the entire prostate gland, predominantly performed via Robotic-Assisted Laparoscopic Prostatectomy (RALP), which offers greater precision and faster recovery.

6.3 Radiotherapy

  • External Beam Radiotherapy (EBRT): Directs high-energy beams at the prostate from outside the body.
  • Brachytherapy: The surgical implantation of radioactive “seeds” directly into the prostate tissue.

6.4 Hormone Therapy (Androgen Deprivation Therapy - ADT)

Cuts off the testosterone fuel supply to cancer cells via medications or surgical castration. It is highly effective but often temporary, as cancer cells can adapt over time.

6.5 Advanced and Emerging Therapies

  • Chemotherapy: Used when prostate cancer has metastasised and no longer responds to hormone therapy.
  • Immunotherapy: Customised therapeutic cancer vaccines designed to train the body’s immune system to attack prostate cancer cells.
  • Targeted Therapy & Radioligand Therapy: Utilising PARP Inhibitors (for BRCA mutations) or highly targeted radiation delivery that specifically binds to prostate cancer markers.

7. Glossary of Key Terminology

To aid in understanding the medical and biological concepts discussed in this document, the following technical terms are defined:

  • Adenocarcinoma: A type of cancer that forms in mucus-secreting glands throughout the body. In the context of the prostate, it is by far the most common form of prostate cancer.
  • Androgens: Male sex hormones, such as testosterone, promote the development of male characteristics and can unfortunately fuel the growth of prostate cancer cells.
  • Apoptosis: The process of programmed cell death, often referred to as “cell suicide.” It is a normal, healthy mechanism the body uses to clear out old, abnormal, or damaged cells (including clearing away cancer cells when triggered by certain dietary compounds or therapies).
  • Brachytherapy: A form of targeted radiotherapy where sealed radioactive sources (often called “seeds”) are implanted directly inside or next to the area requiring treatment.
  • EGCG (Epigallocatechin gallate): EGCG is the most abundant and biologically active polyphenol (a type of catechin) found in green tea. Renowned for its potent antioxidant properties, it helps protect cells from free-radical damage and is widely studied for its potential to reduce inflammation, aid in weight management, and support heart and brain health. Green tea has extremely low absorbability in the upper digestive tract, allowing most of it to reach the large intestine. Here, it acts as a powerful bioactive compound, fundamentally reshaping the microbiome, reducing inflammation, and fortifying the intestinal barrier. Stabilising EGCG ensures that the molecule survives the upper digestive tract. While this “dramatically enhances absorption” into the blood (systemic benefit), it also prevents the molecule from simply disintegrating into useless byproducts. This means more intact EGCG survives to either be absorbed or continue down to the colon to feed beneficial bacteria.
  • Gleason Score: A grading system used by pathologists to evaluate the aggressiveness of prostate cancer based on its microscopic appearance. Scores generally range from 6 (low-grade, slow-growing) to 10 (high-grade, highly aggressive).
  • Metastasis (verb: Metastasise): The spread of cancer cells from the primary site where they first formed to another, distant part of the body (such as the bones or lymph nodes).
  • Phytoestrogens: Plant-derived dietary compounds (found heavily in soya) that can weakly mimic or modulate the effects of the hormone oestrogen in the body, potentially balancing hormonal environments.
  • Prostate-Specific Antigen (PSA): A protein produced by both normal and malignant cells of the prostate gland. Elevated PSA levels in a blood test can be an early clinical indicator of prostate cancer or other prostate issues.
  • Xenograft: The transplantation of living cells, tissues, or organs from one species to another. In cancer research, it often refers to human tumour cells being grown in laboratory mice to study the effects of treatments or diets (like the walnut preclinical studies).

8. Conclusion

Prostate cancer management has evolved into an era of highly sophisticated, targeted treatments. A proactive approach, focusing on early detection, adopting a plant-forward diet rich in superfoods like cooked tomatoes and walnuts, and maintaining an active lifestyle, forms the bedrock of prevention and long-term health. The combination of established medical interventions with an expanding understanding of nutritional oncology continues to improve survival rates and the quality of life for men worldwide.

9. References and Further Reading

  1. Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer. Cancer Research.
  2. Giovannucci, E., et al. (2002). A prospective study of tomato products, lycopene, and prostate cancer risk. Journal of the National Cancer Institute.
  3. Ornish, D., et al. (2005). Intensive lifestyle changes may affect the progression of prostate cancer. The Journal of Urology.
  4. Rider, J. R., et al. (2016). Ejaculation Frequency and Risk of Prostate Cancer. European Urology.
  5. Davis, P. A., et al. (2012). A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice. Cancer Investigation.
  6. Spaccarotella, K. J., et al. (2008). The effect of walnut intake on factors related to prostate and vascular health in older men. Nutrition Journal, 7(13).
  7. American Institute for Cancer Research (AICR). Food Facts: Walnuts.
  8. National Cancer Institute (NCI). (2024). Prostate Cancer Prevention.
  9. NHS: Cancer Data - 2013 to 2020. Cancers with higher incidence rates show improved short-term survival rates. Kaggle
  10. Vitamin D and Human Health. Physiological Functions, Clinical Benefits, and Public Health Implications. RPubs
  11. Can we enhance therapeutic outcomes with plants ? Natural medicines that work alongside pharmaceutics and foods that may protect. Kaggle
  12. Immunity and the Connections of Mental Well Being. The Power of Food to Strengthen the Immune System, to Protect Us. Kaggle
  13. Cancer is a serious business ! Can technology be leveraged to help an early diagnosis ? Kaggle
  14. Nakhleh, M. K., et al. (2016). Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules. ACS Publications